Comfort Ogar is a Senior Pharmacovigilance Manager with the United States Pharmacopeia (USP) and a PhD candidate at the University of Utrecht working on vaccine safety. She has about 20 years of experience in pharmacovigilance and was until recently, a global safety consultant/subject matter expert with the WHO on the novel oral polio type 2 vaccine (nOPV2).

Before her work with the WHO, she was a Principal Technical Advisor and pharmacovigilance Lead for the USAID-funded Medicines, Technologies and Pharmaceutical Services (MTaPS) program led by Management Sciences for Health, where she supported low- and middle-income countries in Africa and Asia to strengthen their regulatory systems with particular focus on pharmacovigilance systems. She worked as a regulator for 18 years at Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) where she was instrumental in establishing the country’s national pharmacovigilance system.

She has an International Master of Public Health (IMPH) from the Hebrew University in Jerusalem and a Master of Medical Sciences (MMSc) in Global Health Delivery from Harvard Medical School. Comfort is the current secretary of the Africa chapter of the International Society of Pharmacovigilance (ISoP). She is married with two children. She loves traveling and mountain biking.